美国心脏协会科学声明:心衰与肺动脉高压基线及激发性有创血流动力学评估方案的标准化
该科学声明由美国心脏协会发布,旨在为静息与激发性右心导管检查提供最佳实践的循证依据和可操作方案。声明涵盖静息右心导管评估、血管扩张剂激发试验评估心衰中肺动脉高压可逆性、容量激发、有创运动血流动力学测试、急性肺动脉高压血管扩张剂测试,以及左心室辅助装置患者的斜坡、反向斜坡和运动研究。声明强调有创血流动力学评估的标准化对优化心衰患者结局至关重要。
要点
- 静息与激发性右心导管检查需标准化方案,以提高血流动力学数据解读的一致性。
- 血管扩张剂激发试验用于评估心衰中肺动脉高压的可逆性。
- 左心室辅助装置患者可行斜坡、反向斜坡及运动研究以指导护理和评估恢复。
核心结论
- 有创血流动力学评估的标准化与进步是优化心衰患者结局的关键步骤。
研究设计与样本
- 美国心脏协会科学声明,基于现有证据提供静息与激发性右心导管检查的最佳实践依据和可操作方案。
主要发现
- 当代血流动力学测试涉及心源性休克、射血分数保留的心衰、肺动脉高压和左心室辅助装置支持等多个方面。
- 关于血流动力学数据标准化和解读的共识有限,激发性血流动力学研究(容量、药物、运动或装置速度相关)同样不统一。
- 缺乏关于激发性研究方案的简明信息是限制其常规使用的常见原因。
关键数值与推荐
- 声明概述了静息右心导管评估的最佳实践、适应证以及血管扩张剂激发试验评估心衰中肺动脉高压可逆性的方法。
- 声明包括容量激发、有创运动血流动力学测试和急性肺动脉高压血管扩张剂测试的讨论。
- 声明详述了左心室辅助装置患者的斜坡、反向斜坡和运动研究以指导护理和评估恢复。
- 声明涵盖了有创血流动力学随时间变化的效用和实际应用,从心源性休克到远程患者监测。
临床怎么用
- 临床可采用声明提供的可操作方案标准化静息和激发性右心导管检查实践。
- 对心衰患者可使用血管扩张剂激发试验评估肺动脉高压可逆性。
- 对左心室辅助装置患者可实施斜坡、反向斜坡和运动研究以指导护理和评估恢复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Circ Heart Fail. 2026 Feb;19(2):e000088. doi: 10.1161/HHF.0000000000000088. Epub 2026 Jan 6. ABSTRACT Contemporary hemodynamic testing intersects with many aspects of cardiovascular disease management. There is a growing understanding that accurate diagnosis, phenotyping, and management of cardiogenic shock, heart failure with preserved ejection fraction, and pulmonary hypertension, and left ventricular assist device support, require both baseline and provocative invasive hemodynamic testing, and often serial measurements. However, there is limited consensus regarding the standardization and interpretation of hemodynamic data. Provocative hemodynamic studies-whether related to volume, drugs, exercise, or device speed-are similarly nonuniform. A frequent limitation to their routine use relates to a lack of concise information regarding provocative study protocols. The aim of this scientific statement is to provide the evidence and rationale underlying best practices for static and provocative right heart catheterization, as well as actionable protocols to standardize their practice. In addition to outlining optimal resting right heart catheterization assessment, indications, and methods for vasodilator challenges to assess pulmonary hypertension reversibility in heart failure, this scientific statement includes discussion on volume challenges, invasive exercise hemodynamic testing, and vasodilator testing for acute pulmonary hypertension. Ramp, reverse-ramp, and exercise studies in patients with left ventricular assist devices are also detailed to help guide care and aid assessment for recovery. The utility and practical application of temporal changes in invasive hemodynamics are covered, from cardiogenic shock to remote patient monitoring. The standardization and advancement of invasive hemodynamic assessment in heart failure represent crucial steps toward optimizing patient outcomes. Continued collaboration across disciplines, enhanced focus on standardization, and investment in emerging technologies are crucial for bridging these gaps and driving innovation. PMID: 41493051 | DOI: 10.1161/HHF.0000000000000088
引用
- 指南共识 · 肺动脉高压:Standardization of Baseline and Provocative Invasive Hemodynamic Protocols for the Evaluation of Heart Failure and Pulmonary Hypertension: A Scientific Statement From the American Heart Association
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。